Switzerland: Debiopharm launches new seed funding initiative

Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with US$150m under management, has launched its new seed funding initiative. It plans to deploy additional capital to support up to 15 seed-stage startups each year. It builds on a track record of investing in 25 companies since the inception of the fund in…

You must be a HMI Subscriber to view this content.

Subscribe Now »